SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intels weaker-than-expected fourth-quarter outlook, citing softer PC demand, higher memory costs and supply constraints, has overshadowed stronger data-center growth and a quarterly earnings beat. Traders are debating whether the sharp selloff reflects real operating concerns or an overreaction.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazons quarterly results and outlook sparked a selloff as investors focused on sharply higher AI infrastructure spending, negative free cash flow, and softer-than-expected revenue and guidance. Traders are divided: some see the spending as a risk to returns, while others argue that accelerating AWS growth supports the investment.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddits post-earnings selloff is tied to a softer fourth-quarter outlook, declining search referrals and weaker U.S. user trends, alongside plans to test requiring logins to access content. Traders debate whether the drop overstates the risk given strong quarterly results or reflects genuine concerns that traffic losses and the login change could hurt user growth and monetization.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Reports of a major Binance security breach are driving discussion, with traders linking the incident to crypto-wide selling and Bitcoins drop toward support levels. The community is split between concerns about exchange security and further downside, and dip-buyers who argue the exchangenot Bitcoin itselfwas compromised.

Sprouts Farmers Market, Inc. engages in the operation of healthy grocery stores. The firm specializes in fresh, natural and organic products. Its products include fresh produce, bulk foods, vitamins and supplements, grocery, meat and seafood, deli, bakery, dairy, frozen foods, body care and natural household items. The company was founded by Stan Boney, Shon Alexander Boney, and Kevin K. Easler on July 11, 2002 and is headquartered in Phoenix, AZ.

Sprouts Farmers Market Inc

Sprouts latest results and outlook are drawing attention after comparable-store sales and customer traffic weakened and management gave a soft next-quarter forecast, prompting a sharp selloff. Traders debate whether this reflects deeper problems with affordability, pricing and store execution or an overdone decline that has made the shares attractive to value buyers.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNows post-earnings selloff is centered on a softer outlook for contracted-revenue growth and a slight earnings miss, despite continued revenue growth and a higher AI target. Traders are debating whether the reaction reflects justified concern about slowing growth, valuation and AIs impact on software, or an overreaction that could create a buying opportunity.

Roblox Corp. engages in the provision of online gaming services. Its platform consists of Roblox Client, Roblox Studio, and Roblox Cloud. Roblox Client is an application that allows users to explore 3D digital worlds. Roblox Studio is the toolset that allows developers and creators to build, publish, and operate 3D experiences and other content accessed with Roblox Client. Roblox Cloud includes the services and infrastructure that power the human co-experience platforms. The company was founded by Erik Cassel and David B. Baszucki in March 2004 and is headquartered in San Mateo, CA.

Roblox Corporation - Ordinary Shares - Class A

Roblox Corp.

Stronger-than-expected Q3 engagement, including activity around the viral game Steal an Egg, and a Wedbush estimate increase are fueling optimism ahead of Robloxs upcoming results. Traders remain divided over whether user activity can translate into bookings growth, with concerns about soft spending and the companys recent weak guidance tempering the bullish view.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

Alphabets quarterly results sparked a record selloff as traders focused on softer Search and advertising performance and heavy AI investment that pressured free cash flow, despite strong Cloud growth. The community is split between concern that spending and AI-driven changes to Search could weigh on cash generation and ad economics, and dip buyers pointing to Cloud momentum and Alphabets longer-term AI prospects.

iShares Silver Trust - Fractional undivided beneficial interests

iShares Silver Trust

A sharp selloff in silver and SLV, with repeated new lows and key support under pressure, dominates the discussion. Traders debate rate and yield concerns versus an oversold dip-buying opportunity, while some attribute the decline to alleged paper-market manipulation.

Listed Funds Trust - Roundhill Magnificent Seven ETF

Roundhill Magnificent Seven ETF

MAGS is drawing attention amid weakness in mega-cap tech, with traders focused on Alphabets earnings-related selloff and concerns about slowing Search growth, AI monetization and heavy investment spending. Some see the pressure as evidence of an AI-fueled bubble and expect further downside, while others view it as a pullback in major tech leaders rather than a lasting break in the long-term story.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

GE HealthCare Wins Approval for MINItrace Magni Cyclotron in Europe

GE HealthCare secures CE Mark certification for MINItrace Magni and expands Copper-64 production capabilities, strengthening its PET imaging and theranostics portfolio.

Are BZH, LNTH, BGMS Obtaining Fair Deals for their Shareholders?

Are BZH, LNTH, BGMS Obtaining Fair Deals for their Shareholders? Are BZH, LNTH, BGMS Obtaining Fair Deals for their Shareholders?PR NewswireNEW YORK, Sept. 29, 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may...

ACT NOW - The M&A Class Action Firm Is Investigating the Merger -- FHB, INDV, ITGR, and LNTH

ACT NOW - The M&A Class Action Firm Is Investigating the Merger -- FHB, INDV, ITGR, and LNTH ACT NOW - The M&A Class Action Firm Is Investigating the Merger -- FHB, INDV, ITGR, and LNTHPR NewswireNEW YORK, Sept. 28, 2026 NEW YORK, Sept. 28, 2026 /PRNewswire/ --Class Action Attorney Juan Monteverde...

Are LNTH, ITGR, CZR Obtaining Fair Deals for their Shareholders?

Are LNTH, ITGR, CZR Obtaining Fair Deals for their Shareholders? Are LNTH, ITGR, CZR Obtaining Fair Deals for their Shareholders?PR NewswireNEW YORK, Sept. 11, 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may...

LNTH Stock Alert: Halper Sadeh LLC is Investigating Whether Lantheus Holdings, Inc. is Obtaining a Fair Price for its Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Lantheus Holdings, Inc. (NASDAQ: LNTH) to Curium US Holdings LLC for $102.50 per share in cash, plus non-transferable Contingent Value Rights providing for up to $12.00 per share in potential additional cash payments...

Are DSGR, LNTH, ATKR Obtaining Fair Deals for their Shareholders?

Are DSGR, LNTH, ATKR Obtaining Fair Deals for their Shareholders? Are DSGR, LNTH, ATKR Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, Aug. 7, 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may...

MRNA, LNTH, BMY, CAPR, RARE Stocks In Focus — These FDA Decisions Could Shape August Trading

Equity

Decisions are due by August 23 at the latest on therapies ranging from an mRNA flu vaccine to a gene therapy for a rare metabolic disorder, putting biotech investors on high alert. 


$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Lantheus Holdings, Inc. (NASDAQ: LNTH)

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Lantheus Holdings, Inc. (NASDAQ: LNTH) $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Lantheus Holdings, Inc. (NASDAQ: LNTH) PR Newswire NEW YORK, Aug. 3, 2026 NEW YORK, Aug. 3, 2026 /PRNewswire...

Are SUPN, ITGR, ATKR, LNTH Obtaining Fair Deals for their Shareholders?

Are SUPN, ITGR, ATKR, LNTH Obtaining Fair Deals for their Shareholders? Are SUPN, ITGR, ATKR, LNTH Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, Aug. 3, 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed...

Shareholder Alert: Ademi LLP investigates whether Lantheus Holdings, Inc. is obtaining a Fair Price for Public Shareholders

Shareholder Alert: Ademi LLP investigates whether Lantheus Holdings, Inc. is obtaining a Fair Price for Public Shareholders Shareholder Alert: Ademi LLP investigates whether Lantheus Holdings, Inc. is obtaining a Fair Price for Public Shareholders PR Newswire MILWAUKEE, Aug. 3, 2026 MILWAUKEE, Aug...

Lantheus Holdings, Inc. engages in the provision of diagnostic imaging and nuclear medicine products. The firm develops products that help healthcare professionals in patient management and outcomes and assists clinicians with the detection of cardiovascular disease. It operates through the following geographical segments U.S. and International. The U.S. segment produces and markets products, radiopharmacies, PMFs, integrated delivery networks, hospitals, clinics, and group practices throughout the United States. The International segment offers direct distribution in Canada and third-party distribution relationships in Europe, Canada, Australia, Asia-Pacific, Central America, and South America. The company was founded in 1956 and is headquartered in Bedford, MA.

Lantheus Holdings Inc

Neutral Sentiment

<ul class="summary-bullets"><li>Moderna is seeking approval for mRNA-1010, its experimental mRNA-based seasonal flu vaccine for adults 50 and older.</li><li>Capricor is seeking full approval for Deramiocel, a cell therapy aimed at heart damage caused by Duchenne muscular dystrophy, after an earlier rejection.&nbsp;</li><li>Ultragenyx is seeking approval for DTX401, a one-time gene therapy for glycogen storage disease type Ia, a rare inherited metabolic disorder, by August 23.</li></ul><p>The U.S. Food and Drug Administration is set to rule on five closely watched treatments in August from Moderna, Lantheus Holdings, Bristol Myers Squibb, Capricor Therapeutics and Ultragenyx Pharmaceutical.</p><p>Decisions are due by August 23 at the latest on therapies ranging from an mRNA flu vaccine to a gene therapy for a rare metabolic disorder, putting biotech investors on high alert as the outcomes could drive sharp near-term moves across the sector.</p><h2 class="st-heading-2">August 5: Moderna’s Flu Shot (<a href="https://stocktwits.com/symbol/MRNA">MRNA</a>)</h2><p>Moderna is seeking approval for mRNA-1010, its experimental mRNA-based seasonal flu vaccine for adults 50 and older. An FDA advisory panel already voted unanimously in favor of the shot in June, and the FDA is slated to decide on its application by August 5.</p><p>The FDA initially refused to file Moderna’s application in early February 2026, citing concerns that the comparator vaccine used in the main trial did not reflect the best available care for older adults. Moderna revised its plan, and now the company is seeking a traditional approval for adults aged 50-64 and an accelerated approval for adults 65 and older. If granted accelerated approval in the patient population, Moderna will be required to conduct another study to confirm effectiveness in the group.</p><h2 class="st-heading-2">August 13: Lantheus’ Alzheimer’s Scan (<a href="https://stocktwits.com/symbol/LNTH">LNTH</a>)</h2><p>Lantheus wants approval for MK-6240, a PET imaging agent that detects tau protein tangles in the brain, a hallmark of Alzheimer’s disease. Doctors would use the scan to help confirm the presence of tau pathology, stage the disease, and guide treatment decisions.</p><p>The FDA accepted the company’s application seeking approval in October and granted it a fast-track designation. The application is based on two late-stage trials in people with early Alzheimer’s disease. In both trials, the scan identified patients with tau pathology and ruled out people without it, to support the application. The FDA will decide on the application by August 13 at the latest.</p><h2 class="st-heading-2"><br>August 17: Bristol Myers Squibb’s Myeloma Drug (<a href="https://stocktwits.com/symbol/BMY">BMY</a>)</h2><p>Bristol Myers Squibb is seeking approval for iberdomide, an oral drug combined with existing medicines for patients whose multiple myeloma has returned or stopped responding, by August 17. It works by helping the immune system attack cancer cells more effectively while also directly killing myeloma cells.</p><p>Bristol Myers’ application was accepted by the FDA in February and granted priority review. The application relies on the large late-stage trial where iberdomide, together with Daratumumab and Dexamethasone, showed a statistically significant improvement in minimal residual disease (MRD) negativity rates compared to control arms. MRD negativity means no detectable cancer cells remain after treatment — an early sign of deep response.</p><h2 class="st-heading-2">August 22: Capricor’s Duchenne Therapy (<a href="https://stocktwits.com/symbol/CAPR">CAPR</a>)</h2><p>Capricor is seeking full approval for Deramiocel, a cell therapy aimed at heart damage caused by Duchenne muscular dystrophy. After an earlier rejection, the company submitted new data from its late-stage HOPE-3 trial to the FDA.</p><p>However, in July, an advisory committee voted 9–3 against the claim that the available evidence provides substantial proof of effectiveness for treating DMD cardiomyopathy. The vote is non-binding, meaning the FDA could still approve the therapy.</p><h2 class="st-heading-2">August 23: Ultragenyx’s Gene Therapy (<a href="https://stocktwits.com/symbol/RARE">RARE</a>)</h2><p>Ultragenyx is seeking approval for DTX401, a one-time gene therapy for glycogen storage disease type Ia, a rare inherited metabolic disorder, by August 23. People with GSDIa cannot release stored sugar from the liver, leading to dangerous drops in blood sugar (hypoglycemia) during fasting, excess glycogen buildup in the liver and kidneys, and other long-term complications. &nbsp;</p><p>The FDA granted priority review to Ultragenyx’s application in February. There are currently no approved treatments that address the underlying cause of GSDIa.</p><h2 class="st-heading-2">How Did Retail Traders React?</h2><p>On Stocktwits, retail sentiment around MRNA trended in the ‘bearish’ territory at the time of writing, while sentiment around RARE and LNTH stayed at ‘neutral’ levels. Sentiment around CAPR and BMY was ‘extremely bullish’ at the time of writing.</p><p>While MRNA stock has gained 87% year-to-date, LNTH has added 52%, BMY 21%, and RARE 9%, while CAPR fell 85%.&nbsp;</p><p>Read More: <a href="https://stocktwits.com/news-articles/markets/equity/nvax-stock-rises-ahead-of-q2-earnings-as-focus-shifts-to-licensing-deals/cZoTFaURJ3L">NVAX Stock Rises Ahead Of Q2 Earnings As Focus Shifts To Licensing Deals</a></p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p>

A sign for the Food And Drug Administration is seen outside of the headquarters on July 20, 2020 in White Oak, Maryland. (Photo by Sarah Silbiger/Getty Images)

Moderna is seeking approval for mRNA-1010, its experimental mRNA-based seasonal flu vaccine for adults 50 and older.Capricor is seeking full approval for Deramiocel, a cell therapy aimed at heart damage caused by Duchenne muscular dystrophy, after an earl

Bristol-Myers Squibb Co.

Capricor Therapeutics Inc

Moderna Inc

Ultragenyx Pharmaceutical Inc

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$100.32
Prev Close	$100.10
Open	$100.49
Dividend Yield	0.00%
50-Day Moving Average	$100.25
Beta	0.44
Avg. Volume	1.04M
PE Ratio	24.25

52-Week High	$111.86
52-Week Low	$50.16
Market Capitalization	$6.54B
EPS (Annual)	$3.41
Price to Book	4.99
Revenue Per Employee	$1.29M

Feed

News

Sentiment

Earnings

Fundamentals

Info

LNTH Fundamentals